Crinetics Pharmaceuticals, Inc.
CRNX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $3,924 | $2,697 | $3,123 | $4,678 |
| - Cash | $111 | $54 | $95 | $265 |
| + Debt | $49 | $50 | $51 | $52 |
| Enterprise Value | $3,862 | $2,694 | $3,079 | $4,465 |
| Revenue | $0 | $1 | $0 | $0 |
| % Growth | -86.1% | 185.6% | – | – |
| Gross Profit | -$90 | $1 | $0 | $0 |
| % Margin | -63,161.5% | 100% | 100% | – |
| EBITDA | -$129 | -$128 | -$110 | -$94 |
| % Margin | -90,265% | -12,430% | -30,603.9% | – |
| Net Income | -$130 | -$116 | -$97 | -$81 |
| % Margin | -90,972.7% | -11,216% | -26,807.2% | – |
| EPS Diluted | -1.38 | -1.23 | -1.04 | -0.88 |
| % Growth | -12.2% | -18.3% | -18.2% | – |
| Operating Cash Flow | -$111 | -$86 | -$88 | -$65 |
| Capital Expenditures | -$1 | -$3 | -$1 | -$1 |
| Free Cash Flow | -$112 | -$89 | -$90 | -$66 |